Latest La Jolla Institute Stories
A major study from researchers at the La Jolla Institute for Allergy and Immunology provides new revelations about the intricate pathways involved in turning on T cells, the body's most important disease-fighting cells, and was published today in the prestigious scientific journal Nature.
As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design.
A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today.
Most people probably know that heart disease remains the nation's No. 1 killer.
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs.
Researchers at the La Jolla Institute for Allergy & Immunology have proven – for the first time in human tissues -- the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas.
La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.
A war is being waged in the pancreases of millions of people throughout the world.
Researchers at the La Jolla Institute for Allergy & Immunology have identified a previously unknown mechanism that generates protective immune memory cells to fight recurring infections at the body's mucosal linings – which include the mouth, the intestines, the lungs and other areas.
Most of the time, the immune system is the body's protector, warding off invading viruses and bacteria before they can lead to infection and disease.
- To give a box on the ear to.